In a study aiming to determine if EGFR mediates the pathogenesis of hyperlipidemia/obesity-related cardiac diseases, EGFR inhibition significantly ameliorated myocardial fibrosis, apoptosis, and inflammation in two rat models of obesity (Li et al., 2016). This evidence concerns the gene EGFR and heart disorder.